All instruments
Concord Biotech Limited
- Stock
- CONCORDBIO
- NSE
- ₹1,339.00−1.06%
- Delayed close, 16 Oct
Details
- INE338H01029
- Healthcare
- Pharmaceuticals
- Face value ₹1
- Market cap ₹14,008 Cr
Paid for 3 years without a break
Dividend per share by FY
Split-adjusted · FY27 to date · FY of the ex-date
| Financial year | Total dividend |
|---|---|
| FY25 | ₹8.75 |
| FY26 | ₹10.70 |
| FY27 | ₹7.55 |
TTM payout
₹7.55
1 payout in 12 months
Yield
0.56%
Dividend yield · trailing 12 months
52-wk closing range ₹1,014.80 – ₹1,587.50
Yield and payout totals recalculated 19 Oct 2026.
Came to market
- Listed
- 18 Aug 2023
- 3 years 2 months ago
- Issue price
- ₹741.00
- at the offer
- First dividend
- 10 months
- after listing
Recent payouts
· 3 on record since FY25| Ex-date | Type | Record date | Amount |
|---|---|---|---|
| 24 Jul 2026 | Final | same day | ₹7.55 |
| 03 Sep 2025 | Final | same day | ₹10.70 |
| 21 Jun 2024 | Final | 22 Jun 2024 | ₹8.75 |
Income calculator
₹559
Expected income per year, before tax, at the current 0.56% yield
≈ 74 shares at ₹1,339.00, using ₹99,086 of the ₹1,00,000. Based on the last twelve months’ payouts — not a forecast, and dividends are taxed at your own slab rate.
Similar current yields
Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.